Asymmetric conformational changes in a GPCR dimer controlled by G-proteins

被引:124
|
作者
Damian, Marjorie
Martin, Aimee
Mesnier, Danielle
Pin, Jean-Philippe
Baneres, Jean-Louis
机构
[1] Univ Montpellier I, CNRS, UMR 5074, Fac Pharm,Lab Chim Biomol & Interact Biol, F-34093 Montpellier 5, France
[2] Univ Montpellier I, Montpellier, France
[3] CNRS, UMR 5203, Montpellier, France
[4] INSERM, U661, Montpellier, France
[5] Univ Montpellier 2, Montpellier, France
[6] Inst Genom Fonctionnelle, Dept Mol Pharmacol, Montpellier, France
来源
EMBO JOURNAL | 2006年 / 25卷 / 24期
关键词
activation; asymmetry; dimer; GPCR; G-protein;
D O I
10.1038/sj.emboj.7601449
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
G-protein-coupled receptors (GPCRs) are key players in cell communication. Although long considered as monomeric, it now appears that these heptahelical proteins can form homo- or heterodimers. Here, we analyzed the conformational changes in each subunit of a receptor dimer resulting from agonist binding to either one or both subunits by measuring the fluorescent properties of a leukotriene B4 receptor dimer with a single 5-hydroxytryptophanlabeled protomer. We show that a receptor dimer with only a single agonist-occupied subunit can trigger G-protein activation. We also show that the two subunits of the receptor dimer in the G-protein-coupled state differ in their conformation, even when both are liganded by the agonist. No such asymmetric conformational changes are observed in the absence of G-protein, indicating that the interaction of the G-protein with the receptor dimer brings specific constraints that prevent a symmetric functioning of this dimer. These data open new options for the differential signaling properties of GPCR dimers.
引用
收藏
页码:5693 / 5702
页数:10
相关论文
共 50 条
  • [41] Modulation of receptors and G-proteins
    Angeli, P
    MEDICINAL CHEMISTRY RESEARCH, 2004, 13 (1-2) : 34 - 37
  • [42] STRUCTURE AND FUNCTION OF G-PROTEINS
    OLATE, J
    ALLENDE, JE
    PHARMACOLOGY & THERAPEUTICS, 1991, 51 (03) : 403 - 419
  • [43] SIGNAL TRANSDUCTION BY G-PROTEINS
    BIRNBAUMER, L
    CODINA, J
    MATTERA, R
    YATANI, A
    SCHERER, N
    TORO, MJ
    BROWN, AM
    KIDNEY INTERNATIONAL, 1987, 32 : S14 - S37
  • [44] LIPID MODIFICATIONS OF G-PROTEINS
    CASEY, PJ
    CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (02) : 219 - 225
  • [45] G-proteins and intimal hyperplasia
    Davies, MG
    JOURNAL OF VASCULAR SURGERY, 2001, 33 (06) : 1310 - 1312
  • [46] G-PROTEINS IN SIGNAL TRANSDUCTION
    BIRNBAUMER, L
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1990, 30 : 675 - 705
  • [47] SIGNAL TRANSDUCTION BY G-PROTEINS
    IYENGAR, R
    BIRNBAUMER, L
    ISI ATLAS OF SCIENCE-PHARMACOLOGY, 1987, 1 (03): : 213 - 221
  • [48] WATCHING G-PROTEINS AT WORK
    UHL, R
    WAGNER, R
    RYBA, N
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1988, 369 (09): : 934 - 934
  • [49] COVALENT MODIFICATIONS OF G-PROTEINS
    YAMANE, HK
    FUNG, BKK
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1993, 33 : 201 - 241
  • [50] LIPID MODIFICATION OF G-PROTEINS
    KINSELLA, BT
    OMAHONY, DJ
    TRENDS IN CARDIOVASCULAR MEDICINE, 1994, 4 (01) : 27 - 34